ScreenerHero

SHLTN SHL Telemedicine Ltd.

SWX · CH · Healthcare · Health Information Services · shl-telemedicine.com
1.000CHF-6.54%Mkt Cap: 42.29M $P/E: —

SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full,…

Industry Peers

Health Information Services
Screen all
VEEV
Veeva Systems Inc.
$45.89BUSDP/E 46.5
TEM
Tempus AI, Inc. - Class A Common Stock
$13.83BUSD
BTSG
BrightSpring Health Services, Inc. - Common Stock
$11.92BUSDP/E 53.8
HNGE
Hinge Health, Inc.
$7.94BUSDP/E 32.5
HQY
HealthEquity, Inc. - Common Stock
$7.45BUSDP/E 32.5
DOCS
Doximity, Inc.
$5.09BUSDP/E 33.6
WAY
Waystar Holding Corp. - Common Stock
$4.76BUSDP/E 35.4
HTFL
Heartflow, Inc. - Common Stock
$4.29BUSD
PRVA
Privia Health Group, Inc. - Common Stock
$2.59BUSDP/E 92.3
SDGR
Schrodinger, Inc. - Common Stock
$2.27BUSD
OMCL
Omnicell, Inc. - Common Stock
$1.53BUSDP/E 40.0
CERT
Certara, Inc. - Common Stock
$1.43BUSD
OMDA
Omada Health, Inc. - Common Stock
$1.25BUSDP/E 30.4
GDRX
GoodRx Holdings, Inc. - Class A Common Stock
$1.12BUSDP/E 54.7
TDOC
Teladoc Health, Inc.
$1.05BUSD
HSTM
HealthStream, Inc. - Common Stock
$942.97MUSDP/E 42.8
SOPH
SOPHiA GENETICS SA - Ordinary Shares
$686.98MUSD
PHR
Phreesia, Inc.
$643.68MUSDP/E 61.0
WEAV
Weave Communications, Inc.
$592.12MUSD
RAY-B
RaySearch Laboratories AB (publ)
$523.69MUSDP/E 29.5

Key Statistics

Company
Market Cap42.29M USD
Enterprise Value35.43M USD
Revenue (TTM)70.87M USD
Gross Profit31.47M USD
Net Income (TTM)-17.55M USD
Revenue/Share1.98 CHF
Last Price1.000 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees526
CountryCH
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)1.27
PEG—
EV/EBITDA-13.26
EV/Revenue0.50
P/S0.64
P/B1.10
EPS (TTM)-0.54
EPS (Forward)0.84
52W Range
0.660041% of range1.485
52W High1.485 CHF
52W Low0.6600 CHF
Profitability
Gross Margin46.98%
Oper. Margin-8.87%
EBITDA Margin-3.77%
Profit Margin-26.20%
ROE-35.13%
ROA-18.17%
Growth
Revenue Growth12.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.07M USD
CapEx (TTM)3.49M USD
FCF Margin6.91%
FCF Yield11.58%
Net Debt-9.83M USD
Net Debt/EBITDA3.68
Balance Sheet
Debt/Equity0.30
Current Ratio1.08
Quick Ratio1.04
Book Value/Sh0.97 CHF
Cash/Share0.52 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CHF
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 10, 2019
Pay DateApr 16, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.37.06M
Float16.45M
Insiders51.85%
Institutions23.03%
Technical
SMA 501.063 (-5.9%)
SMA 2001.048 (-4.5%)
Beta-0.16
S&P 52W Chg14.58%
Avg Vol (30d)7.31K
Avg Vol (10d)6.35K
Technical Indicators
RSI (14)52.3
MACD0.0006
MACD Signal-0.0018
MACD Hist.+0.0024
BB Upper1.107 CHF
BB Middle1.056 CHF
BB Lower1.005 CHF
BB Width9.65%
ATR (14)0.0461 CHF
Vol Ratio (20d)0.55x